CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 79% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
Country • Select Country
    Entity • The products and services listed on this website are not available to US residents.
    English العَرَبِيَّة Deutsch ελληνικά Español Français Italiano Magyar Nederlands Polski Română Русский 简体中文 繁體中文

    Trade PhenomeX Inc. - CELL CFD

    0.9967
    0.31%
    • Summary
    • Historical Data
    • Events
    • Income Statement
    • Balance Sheet
    • Cash Flow
    • Ownership
    Trading Conditions
    Spread 0.0031
    Long position overnight fee

    Long position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee -0.026235 %
    Charges from full value of position ($-4.98)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		-0.026235%
    Short position overnight fee

    Short position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee 0.004012 %
    Charges from full value of position ($0.76)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		0.004012%
    Overnight fee time 22:00 (UTC)
    Min traded quantity 1
    Currency USD
    Margin 5%
    Stock exchange United States of America
    Commission on trade 0%

    *Information provided by Capital.com

    Bruker Cellular Analysis Inc ESG Risk Ratings

    High Medium Low Negligible

    ‘D’ score indicates poor relative ESG performance and insufficient degree of transparency in reporting material ESG data publicly.

    More ESG coverage

    Key Stats
    Prev. Close* 0.9936
    Open* 0.9957
    1-Year Change* -67.03%
    Day's Range* 0.9956 - 0.9971
    52 wk Range 0.38-4.12
    Average Volume (10 days) 1.95M
    Average Volume (3 months) 34.38M
    Market Cap 97.32M
    P/E Ratio -100.00K
    Shares Outstanding 98.98M
    Revenue 71.82M
    EPS -1.54
    Dividend (Yield %) N/A
    Beta -100.00K
    Next Earnings Date Nov 6, 2023

    All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date Close Change Change (%) Open High Low
    Sep 29, 2023 0.9967 0.0010 0.10% 0.9957 0.9971 0.9956
    Sep 28, 2023 0.9936 0.0010 0.10% 0.9926 0.9971 0.9915
    Sep 27, 2023 0.9916 0.0015 0.15% 0.9901 0.9919 0.9901
    Sep 26, 2023 0.9915 0.0008 0.08% 0.9907 0.9919 0.9901
    Sep 25, 2023 0.9909 0.0021 0.21% 0.9888 0.9953 0.9888
    Sep 22, 2023 0.9890 0.0003 0.03% 0.9887 0.9892 0.9866
    Sep 21, 2023 0.9886 -0.0001 -0.01% 0.9887 0.9943 0.9861
    Sep 20, 2023 0.9887 0.0000 0.00% 0.9887 0.9902 0.9885
    Sep 19, 2023 0.9887 0.0041 0.42% 0.9846 0.9899 0.9845
    Sep 18, 2023 0.9847 0.0011 0.11% 0.9836 0.9946 0.9836
    Sep 15, 2023 0.9857 0.0021 0.21% 0.9836 0.9913 0.9819
    Sep 14, 2023 0.9817 0.0000 0.00% 0.9817 0.9838 0.9816
    Sep 13, 2023 0.9818 0.0002 0.02% 0.9816 0.9873 0.9807
    Sep 12, 2023 0.9820 -0.0016 -0.16% 0.9836 0.9836 0.9797
    Sep 11, 2023 0.9804 -0.0012 -0.12% 0.9816 0.9840 0.9796
    Sep 8, 2023 0.9811 -0.0007 -0.07% 0.9818 0.9838 0.9806
    Sep 7, 2023 0.9818 0.0007 0.07% 0.9811 0.9839 0.9807
    Sep 6, 2023 0.9827 0.0041 0.42% 0.9786 0.9851 0.9786
    Sep 5, 2023 0.9806 0.0128 1.32% 0.9678 0.9883 0.9593
    Sep 1, 2023 0.9687 0.0100 1.04% 0.9587 0.9741 0.9587

    PhenomeX Inc. Events

    Time (UTC) Country Event
    Wednesday, February 21, 2024

    Time (UTC)

    21:00

    Country

    US

    Event

    Q4 2023 PhenomeX Inc Earnings Release
    Q4 2023 PhenomeX Inc Earnings Release

    Forecast

    -

    Previous

    -
    View all events
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total revenue 78.595 85.388 64.303 56.693 31.299
    Revenue 78.595 85.388 64.303 56.693 31.299
    Cost of Revenue, Total 24.814 28.837 19.748 13.217 8.181
    Gross Profit 53.781 56.551 44.555 43.476 23.118
    Total Operating Expense 176.649 156.177 104.697 73.23 52.458
    Selling/General/Admin. Expenses, Total 95.115 68.787 37.709 21.599 15.2
    Research & Development 53.207 58.553 47.24 38.414 29.077
    Operating Income -98.054 -70.789 -40.394 -16.537 -21.159
    Interest Income (Expense), Net Non-Operating 0.114 -0.99 -1.098 -0.516 -1.332
    Other, Net 0.082 -1.18 -0.777
    Net Income Before Taxes -97.94 -71.779 -41.41 -18.233 -23.268
    Net Income After Taxes -98.04 -71.724 -41.584 -18.302 -23.337
    Net Income Before Extra. Items -98.04 -71.724 -41.584 -18.302 -23.337
    Net Income -98.04 -71.724 -41.584 -18.302 -23.337
    Total Adjustments to Net Income 0 -1.735 -3.198 -3.198
    Income Available to Common Excl. Extra. Items -98.04 -71.724 -43.319 -21.5 -26.535
    Income Available to Common Incl. Extra. Items -98.04 -71.724 -43.319 -21.5 -26.535
    Diluted Net Income -98.04 -71.724 -43.319 -21.5 -26.535
    Diluted Weighted Average Shares 68.8686 66.7071 64.4863 61.6439 61.6439
    Diluted EPS Excluding Extraordinary Items -1.42358 -1.07521 -0.67176 -0.34878 -0.43046
    Dividends per Share - Common Stock Primary Issue 0 0
    Diluted Normalized EPS -1.39042 -1.07423 -0.65664 -0.34034 -0.42307
    Unusual Expense (Income) 3.513
    Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
    Total revenue 14.062 18.516 17.841 21.398 19.15
    Revenue 14.062 18.516 17.841 21.398 19.15
    Cost of Revenue, Total 8.019 5.088 5.838 6.373 6.224
    Gross Profit 6.043 13.428 12.003 15.025 12.926
    Total Operating Expense 59.469 41.146 47.539 42.934 44.697
    Selling/General/Admin. Expenses, Total 26.258 26.547 30.768 26.525 20.295
    Research & Development 9.342 8.421 8.478 8.978 18.178
    Operating Income -45.407 -22.63 -29.698 -21.536 -25.547
    Interest Income (Expense), Net Non-Operating -0.938 0.443 0.451 -0.008 -0.196
    Net Income Before Taxes -50.194 -23.399 -29.247 -21.544 -25.743
    Net Income After Taxes -50.245 -23.419 -29.301 -21.566 -25.747
    Net Income Before Extra. Items -50.245 -23.419 -29.301 -21.566 -25.747
    Net Income -50.245 -23.419 -29.301 -21.566 -25.747
    Income Available to Common Excl. Extra. Items -50.245 -23.419 -29.301 -21.566 -25.747
    Income Available to Common Incl. Extra. Items -50.245 -23.419 -29.301 -21.566 -25.747
    Diluted Net Income -50.245 -23.419 -29.301 -21.566 -25.747
    Diluted Weighted Average Shares 98.9008 75.7598 71.3996 68.3841 67.9857
    Diluted EPS Excluding Extraordinary Items -0.50803 -0.30912 -0.41038 -0.31537 -0.37871
    Dividends per Share - Common Stock Primary Issue 0 0 0 0
    Diluted Normalized EPS -0.40386 -0.29977 -0.38803 -0.30531 -0.37871
    Unusual Expense (Income) 15.85 1.09 2.455 1.058
    Other, Net -3.849 -1.212
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total Current Assets 176.952 230.57 265.569 105.347 118.995
    Cash and Short Term Investments 132.774 178.096 233.408 81.033 99.617
    Cash & Equivalents 86.522 178.096 233.408 81.033 99.617
    Total Receivables, Net 19.817 27.678 14.249 14.568 12.369
    Accounts Receivable - Trade, Net 19.817 27.678 14.249 14.568 12.369
    Total Inventory 18.861 14.547 11.047 7.181 2.866
    Other Current Assets, Total 3.475 7.305 4.464 2.565 4.143
    Total Assets 226.094 287.253 299.658 131.009 133.819
    Property/Plant/Equipment, Total - Net 47.173 54.052 31.262 24.257 14.104
    Property/Plant/Equipment, Total - Gross 76.397 75.85 47.6 36.424 24.065
    Accumulated Depreciation, Total -29.224 -21.798 -16.338 -12.167 -9.961
    Other Long Term Assets, Total 1.42 1.561 2.827 1.405 0.72
    Total Current Liabilities 45.49 32.751 28.968 24.919 15.348
    Accounts Payable 10.092 8.198 3.491 3.239 2.702
    Accrued Expenses 19.721 11.287 7.938 5.266 2.509
    Notes Payable/Short Term Debt 0 0 0 0 0
    Current Port. of LT Debt/Capital Leases 4.966 0 11.594 5.765 0
    Other Current Liabilities, Total 10.711 13.266 5.945 10.649 10.137
    Total Liabilities 84.039 79.037 54.877 47.226 36.188
    Total Long Term Debt 14.86 19.762 8.301 14.062 19.763
    Long Term Debt 14.86 19.762 8.301 14.062 19.763
    Other Liabilities, Total 23.689 26.524 17.608 8.245 1.077
    Total Equity 142.055 208.216 244.781 83.783 97.631
    Preferred Stock - Non Redeemable, Net 0 0 224.769 224.769
    Additional Paid-In Capital 503.708 471.82 436.662 9.314 4.86
    Retained Earnings (Accumulated Deficit) -361.648 -263.608 -191.884 -150.3 -131.998
    Total Liabilities & Shareholders’ Equity 226.094 287.253 299.658 131.009 133.819
    Total Common Shares Outstanding 72.1691 67.5955 64.4863 61.6439 61.6439
    Prepaid Expenses 2.025 2.944 2.401
    Common Stock 0.004 0.004 0.003
    Note Receivable - Long Term 0.549 1.07
    Short Term Investments 46.252
    Other Equity, Total -0.009
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Total Current Assets 131.642 176.952 180.961 192.47 208.364
    Cash and Short Term Investments 51.606 132.774 134.715 152.385 164.674
    Cash & Equivalents 51.606 86.522 120.64 143.024 164.674
    Total Receivables, Net 25.486 19.817 21.557 17.58 19.617
    Accounts Receivable - Trade, Net 25.486 19.817 21.557 17.58 19.617
    Total Inventory 45.539 18.861 15.706 15.664 15.665
    Prepaid Expenses 3.534 2.025 2.414 0.399 1.64
    Other Current Assets, Total 5.477 3.475 6.569 6.442 6.768
    Total Assets 300.561 226.094 234.884 248.706 265.857
    Property/Plant/Equipment, Total - Net 61.291 47.173 51.822 53.839 55.238
    Property/Plant/Equipment, Total - Gross 99.542 76.397 79.405 79.605 78.681
    Accumulated Depreciation, Total -38.251 -29.224 -27.583 -25.766 -23.443
    Note Receivable - Long Term 0.514 0.549 0.681 0.996 0.571
    Other Long Term Assets, Total 71.796 1.42 1.42 1.401 1.684
    Total Current Liabilities 47.442 45.49 34.38 29.138 27.711
    Accounts Payable 17.051 10.092 7.921 8.499 8.015
    Accrued Expenses 17.856 19.721 14.819 11.285 9.275
    Notes Payable/Short Term Debt 0 0 0 0 0
    Current Port. of LT Debt/Capital Leases 0 4.966 2.483 0
    Other Current Liabilities, Total 12.535 10.711 9.157 9.354 10.421
    Total Liabilities 142.821 84.039 76.701 74.29 72.656
    Total Long Term Debt 68.886 14.86 17.327 19.794 19.778
    Long Term Debt 68.886 14.86 17.327 19.794 19.778
    Other Liabilities, Total 26.493 23.689 24.994 25.358 25.167
    Total Equity 157.74 142.055 158.183 174.416 193.201
    Preferred Stock - Non Redeemable, Net
    Common Stock 0.005 0.004 0.004 0.004 0.004
    Additional Paid-In Capital 542.805 503.708 490.544 485.212 478.231
    Retained Earnings (Accumulated Deficit) -385.067 -361.648 -332.347 -310.781 -285.034
    Total Liabilities & Shareholders’ Equity 300.561 226.094 234.884 248.706 265.857
    Total Common Shares Outstanding 98.7449 72.1691 68.575 68.2739 67.8201
    Short Term Investments 0 46.252 14.075 9.361
    Other Equity, Total -0.003 -0.009 -0.018 -0.019
    Goodwill, Net 12.246
    Intangibles, Net 23.072
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Net income/Starting Line -98.04 -71.724 -41.584 -18.302 -23.337
    Cash From Operating Activities -47.539 -53.128 -35.852 -10.533 -13.535
    Cash From Operating Activities 9.004 5.598 5.102 4.842 4.197
    Non-Cash Items 28.042 24.354 12.848 7.492 3.913
    Cash Taxes Paid 0.037 0.003 0.108 0.109 0.001
    Cash Interest Paid 0.563 0.969 1.368 1.361 1.761
    Changes in Working Capital 13.455 -11.356 -12.218 -4.565 1.692
    Cash From Investing Activities -53.982 -15.825 -3.289 -9.073 -8.418
    Capital Expenditures -8.076 -15.825 -3.289 -8.423 -7.418
    Other Investing Cash Flow Items, Total -45.906 0 0 -0.65 -1
    Cash From Financing Activities 9.677 13.641 191.516 1.022 95.557
    Financing Cash Flow Items 0 -0.3 -2.65 0 -0.273
    Issuance (Retirement) of Stock, Net 9.677 13.941 194.166 1.022 94.962
    Issuance (Retirement) of Debt, Net 0 0 0 0.868
    Net Change in Cash -91.844 -55.312 152.375 -18.584 73.604
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Net income/Starting Line -23.419 -98.04 -68.739 -47.173 -21.426
    Cash From Operating Activities -19.553 -47.539 -37.503 -20.588 -10.069
    Cash From Operating Activities 2.1 9.004 6.58 4.431 1.944
    Non-Cash Items 7.217 28.042 20.302 14.305 6.367
    Cash Interest Paid 0.439 0.563 0.422 0.278 0.137
    Changes in Working Capital -5.451 13.455 4.354 7.849 3.046
    Cash From Investing Activities 5.735 -53.982 -21.775 -16.13 -4.375
    Capital Expenditures -0.414 -8.076 -7.732 -6.758 -4.375
    Cash From Financing Activities 48.995 9.677 1.552 1.376 1.022
    Issuance (Retirement) of Stock, Net 0.195 9.677 1.552 1.376 1.022
    Net Change in Cash 35.177 -91.844 -57.726 -35.342 -13.422
    Cash Taxes Paid 0.019 0.037 0.01 0
    Financing Cash Flow Items -1.2 0 0 0
    Other Investing Cash Flow Items, Total 6.149 -45.906 -14.043 -9.372
    Issuance (Retirement) of Debt, Net 50 0

    Trading calculator

    Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

    Trade commission
    0
    • 1:1
    Leverage
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    Investment
    Trade size (Leverage x Investement):
    Open

    Close

    Short Long
    Past performance is not a reliable indicator of future results For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)
    Profit/Loss

    For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

    Berkeley Lights, Inc. Company profile

    About Berkeley Lights Inc

    Berkeley Lights, Inc. is a digital cell biology company. The Company is focused on enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products. The Company's Berkeley Lights Platform captures deep phenotypic, functional and genotypic information for tens of thousands of single cells in parallel and can also deliver the live biology customers desire in the form of the best cells. Berkeley Lights platform is a fully integrated, end-to-end solution, consisting of consumables, including its OptoSelect chips and reagent kits, advanced automation systems, and advanced application and workflow software. The Company's platform leverages its OptoElectro Positioning (OEP) technology, which provides deterministic positioning of living single cells and other micro-objects using light. The Company's software products include Cell Analysis Suite (CAS), Workflow Runner/Builder, Assay Analyzer, Image Analyzer, and PrimeSeq.

    Financial summary

    BRIEF: For the fiscal year ended 31 December 2021, Berkeley Lights Inc revenues increased 33% to $85.4M. Net loss applicable to common stockholders increased 66% to $71.7M. Revenues reflect Antibody Therapeutics segment increase of 24% to $64.3M, Synthetic Biology segment increase of 11% to $9M, Asia Pacific segment increase of 82% to $35.2M, North America segment increase of 27% to $41.2M.

    Industry: Biotechnology & Medical Research (NEC)

    5858 Horton Street
    Suite 320
    EMERYVILLE
    CALIFORNIA 94608
    US

    Income Statement

    • Annual
    • Quarterly

    News

    CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

    CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

    12:39, 30 November 2023

    Euro Zone CPI expected to continue dropping; economists warn about cutting too soon

    EZ PI expected to drop further but speed of decline

    08:16, 29 November 2023

    A weaker Dollar drives gold higher

    Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.

    13:49, 28 November 2023

    Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain

    US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.

    13:20, 28 November 2023

    RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023

    The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.

    13:04, 28 November 2023

    Crude prices slide on OPEC+ uncertainty

    Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.

    12:55, 28 November 2023
    GBP

    UK AUTUMN BUDGET: Will Hunt cut taxes? How will GBP react this time around?

    UK Chancellor Hunt will deliver the 2023 autumn statement to MPs on Wednesday 22 November.

    10:48, 21 November 2023

    People also watch

    US100

    16,001.20 Price
    +0.470% 1D Chg, %
    Long position overnight fee -0.0262%
    Short position overnight fee 0.0040%
    Overnight fee time 22:00 (UTC)
    Spread 7.0

    BTC/USD

    38,882.05 Price
    +0.080% 1D Chg, %
    Long position overnight fee -0.0616%
    Short position overnight fee 0.0137%
    Overnight fee time 22:00 (UTC)
    Spread 106.00

    XRP/USD

    0.62 Price
    +0.410% 1D Chg, %
    Long position overnight fee -0.0753%
    Short position overnight fee 0.0069%
    Overnight fee time 22:00 (UTC)
    Spread 0.01168

    Oil - Crude

    74.50 Price
    -1.560% 1D Chg, %
    Long position overnight fee -0.0136%
    Short position overnight fee -0.0083%
    Overnight fee time 22:00 (UTC)
    Spread 0.040

    Still looking for a broker you can trust?

    Join the 570.000+ traders worldwide that chose to trade with Capital.com

    1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading